212 related articles for article (PubMed ID: 16225943)
21. [The impact of integrating images of positron emission tomography with computed tomography simulation on radiation therapy planning].
Touboul E; Deniaud-Alexandre E; Moureau-Zabotto L; Lerouge D
Cancer Radiother; 2004 Nov; 8 Suppl 1():S29-35. PubMed ID: 15679244
[TBL] [Abstract][Full Text] [Related]
22. Response to radiation.
Rosenzweig KE; Fox JL; Giraud P
Semin Radiat Oncol; 2004 Oct; 14(4):322-5. PubMed ID: 15558507
[TBL] [Abstract][Full Text] [Related]
23. [Preliminary study of 18F-FDG PET-CT in defining lymph node radiation target volume for non-small-cell lung cancer patients].
Liu LP; Yu JM; Guo HB; Fu Z; Han AQ; Yang GR
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):453-6. PubMed ID: 17974282
[TBL] [Abstract][Full Text] [Related]
24. Correlation of PET standard uptake value and CT window-level thresholds for target delineation in CT-based radiation treatment planning.
Hong R; Halama J; Bova D; Sethi A; Emami B
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):720-6. PubMed ID: 17293230
[TBL] [Abstract][Full Text] [Related]
25. Positron emission tomography for radiation treatment planning.
Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M
Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216
[TBL] [Abstract][Full Text] [Related]
26. Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives.
Nestle U; Kremp S; Grosu AL
Radiother Oncol; 2006 Nov; 81(2):209-25. PubMed ID: 17064802
[TBL] [Abstract][Full Text] [Related]
27. Value of positron emission tomography for lung cancer staging.
Albes JM; Dohmen BM; Schott U; Schülen E; Wehrmann M; Ziemer G
Eur J Surg Oncol; 2002 Feb; 28(1):55-62. PubMed ID: 11869015
[TBL] [Abstract][Full Text] [Related]
28. Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer.
Messa C; Ceresoli GL; Rizzo G; Artioli D; Cattaneo M; Castellone P; Gregorc V; Picchio M; Landoni C; Fazio F
Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):259-66. PubMed ID: 16172572
[TBL] [Abstract][Full Text] [Related]
29. Use of PET/CT for staging and radiation therapy planning in patients with non-small cell lung cancer.
Mac Manus MP
Q J Nucl Med Mol Imaging; 2010 Oct; 54(5):510-20. PubMed ID: 20927018
[TBL] [Abstract][Full Text] [Related]
30. FDG-PET-based differential uptake volume histograms: a possible approach towards definition of biological target volumes.
Devic S; Mohammed H; Tomic N; Aldelaijan S; De Blois F; Seuntjens J; Lehnert S; Faria S
Br J Radiol; 2016 Jun; 89(1062):20150388. PubMed ID: 27007269
[TBL] [Abstract][Full Text] [Related]
31. 18F-FDG PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer: is a single standardized uptake value threshold approach appropriate?
Biehl KJ; Kong FM; Dehdashti F; Jin JY; Mutic S; El Naqa I; Siegel BA; Bradley JD
J Nucl Med; 2006 Nov; 47(11):1808-12. PubMed ID: 17079814
[TBL] [Abstract][Full Text] [Related]
32. The role of positron emission tomography/computed tomography in radiation therapy planning for patients with lung cancer.
Mac Manus MP; Hicks RJ
Semin Nucl Med; 2012 Sep; 42(5):308-19. PubMed ID: 22840596
[TBL] [Abstract][Full Text] [Related]
33. Defining a radiotherapy target with positron emission tomography.
Black QC; Grills IS; Kestin LL; Wong CY; Wong JW; Martinez AA; Yan D
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1272-82. PubMed ID: 15519800
[TBL] [Abstract][Full Text] [Related]
34. [Interest of FDG-PET for lung cancer radiotherapy].
Thureau S; Mezzani-Saillard S; Modzelewski R; Edet-Sanson A; Dubray B; Vera P
Cancer Radiother; 2011 Oct; 15(6-7):504-8. PubMed ID: 21880535
[TBL] [Abstract][Full Text] [Related]
35. Role of FDG-PET in the diagnosis and management of lung cancer.
Oyen WJ; Bussink J; Verhagen AF; Corstens FH; Bootsma GP
Expert Rev Anticancer Ther; 2004 Aug; 4(4):561-7. PubMed ID: 15270660
[TBL] [Abstract][Full Text] [Related]
36. The registration of diagnostic versus planning fluorodeoxyglucose positron emission tomography/computed tomography in radiotherapy planning for non-small cell lung cancer.
Yap ML; Vinod SK; Shon IA; Fowler A; Lin M; Gabriel G; Holloway LC
Clin Oncol (R Coll Radiol); 2010 Sep; 22(7):554-60. PubMed ID: 20605426
[TBL] [Abstract][Full Text] [Related]
37. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging.
Shim SS; Lee KS; Kim BT; Chung MJ; Lee EJ; Han J; Choi JY; Kwon OJ; Shim YM; Kim S
Radiology; 2005 Sep; 236(3):1011-9. PubMed ID: 16014441
[TBL] [Abstract][Full Text] [Related]
38. [Optimization of radiotherapy planning for non-small cell lung cancer (NSCLC) using 18FDG-PET].
Schmidt S; Nestle U; Walter K; Licht N; Ukena D; Schnabel K; Kirsch CM
Nuklearmedizin; 2002 Oct; 41(5):217-20. PubMed ID: 12418307
[TBL] [Abstract][Full Text] [Related]
39. [A study on the application of 18F-FDG-PET-CT for the radiotherapy of patients with stage III non-small cell lung cancer].
Shandan ; Han B; Pan H; Yu L; Wang R
Zhongguo Fei Ai Za Zhi; 2010 Jul; 13(7):700-5. PubMed ID: 20673486
[TBL] [Abstract][Full Text] [Related]
40. Areas of high 18F-FDG uptake on preradiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for non-small cell lung cancer.
Calais J; Thureau S; Dubray B; Modzelewski R; Thiberville L; Gardin I; Vera P
J Nucl Med; 2015 Feb; 56(2):196-203. PubMed ID: 25572091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]